Thalassemia is a group of blood illnesses that distress the system the body makes hemoglobin. Hemoglobin is a protein found in red blood cells and it carries oxygen throughout the body. The main components that make hemoglobin are of alpha globin and beta globin. When one or more of the genes, controlling the formation of alpha globins is absent or defective it forms alpha thalassemia.MARKET DYNAMICS
The alpha thalassemia market is expected to grow during forecast period owing to key factors such as rising awareness about the disease, rising incidences of congenital birth defects and increasing number of the genetic disorders. The rise in healthcare expenditures are likely to create growth opportunities in the market.MARKET SCOPE
The "Global Alpha Thalassemia Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of alpha thalassemia market with detailed market segmentation by type, diagnosis, end user and geography. The global alpha thalassemia market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading alpha thalassemia market players and offers key trends and opportunities in the market.MARKET SEGMENTATION
The global alpha thalassemia market is segmented on the basis of type, diagnosis and end user. Based on the type market is segmented as silent alpha thalassemia carrier, alpha thalassemia minor, alpha thalassemia trait, hemoglobin H disease, alpha thalassemia major and hydrops fetalis. On the basis of diagnosis the market is classified as prenatal testing, perinatal testing and pre-implantation. Based on the end user the market is divided into hospitals, diagnostic laboratories and others.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global alpha thalassemia market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The alpha thalassemia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting alpha thalassemia market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the alpha thalassemia market in these regions.
The reports cover key developments in the alpha thalassemia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from alpha thalassemia market are anticipated to lucrative growth opportunities in the future with the rising demand for alpha thalassemia market in the global market. Below mentioned is the list of few companies engaged in the alpha thalassemia market.
The report also includes the profiles of key alpha thalassemia market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Trinity Biotech Plc
- Novus Biologicals
- Viennalab Diagnostics Gmbh
- Bio-Rad Laboratories, Inc
- Thermofisher Scienific Corporation Inc
- Bluebird Bio, Inc.
- Natera, Inc.
- EKF Diagnostics
- Sangamo Therapeutics
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.